Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Vaccitech, an Oxford University spinout company developing a universal flu vaccine has secured £20 million in Series A financing.

person getting a flu jab

The round was co-led by new investors GV, Sequoia China, and existing backer Oxford Sciences Innovation, which manages a £600m fund aimed at Oxford University spinouts, and was also joined by Neptune Ventures. This brings the total amount raised by Vaccitech to £30 million since it was established in 2016. Vaccitech is commercialising the research of vaccine development specialists Adrian Hill and Sarah Gilbert, who developed the underpinning technology at the Jenner Institute.

Read the full article

Similar stories

Malaria booster vaccine continues to meet WHO-specified 75% efficacy goal

Researchers from the NDM's Jenner Institute and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ – which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.

The Ling Felce Award to promote cross-disciplinary excellence in bioinformatics

Following on from the tragic death of Dr Ling Felce at the Plain roundabout in March 2022, the CAMS-Oxford Institute within the Nuffield Department of Medicine are seeking funds to start an award in her memory.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

Pandemic Sciences Institute formally launched in Oxford

The University of Oxford’s Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.

CAMS Oxford Institute unveiled at virtual ceremony

Oxford University and the Chinese Academy of Medical Sciences (CAMS) signed a cooperation agreement at a virtual unveiling ceremony of the CAMS Oxford Institute.

Turing Fellowship for NDM researcher

Thirty-three University of Oxford researchers have been named Turing Fellows for the 2021/22 academic year, including Dr Benjamin Schuster-Böckler from the Ludwig Institute for Cancer Research.